Telmisartan Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 13-Oct-2021
No. of pages: 102

This report contains market size and forecasts of Telmisartan in global, including the following market information:

Global Telmisartan Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Telmisartan Market Sales, 2016-2021, 2022-2027, (MT)

Global top five Telmisartan companies in 2020 (%)

The global Telmisartan market was valued at 3342.8 million in 2020 and is projected to reach US$ 3799.5 million by 2027, at a CAGR of 3.3% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Telmisartan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Telmisartan Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Telmisartan Market Segment Percentages, By Type, 2020 (%)

- Injection

- Freeze-Dried Powder

Global Telmisartan Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Telmisartan Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Clinic

- Others

Global Telmisartan Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)

Global Telmisartan Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Telmisartan revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Telmisartan revenues share in global market, 2020 (%)

Key companies Telmisartan sales in global market, 2016-2021 (Estimated), (MT)

Key companies Telmisartan sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Pfizer

- Teva

- Boehringer Ingelheim

- Novartis

- Mylan

- Reddy's Laboratories (UK)

- Hema Pharmaceuticals Pvt

- Bayer

- GSK

- Astellas Pharma Inc

- Nippon Boehringer Ingelheim

- Abbott

- Takeda

- Beijing Wansheng Pharmaceutical

Telmisartan Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Telmisartan Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Telmisartan Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Telmisartan Overall Market Size
2.1 Global Telmisartan Market Size: 2021 VS 2027
2.2 Global Telmisartan Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Telmisartan Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Telmisartan Players in Global Market
3.2 Top Global Telmisartan Companies Ranked by Revenue
3.3 Global Telmisartan Revenue by Companies
3.4 Global Telmisartan Sales by Companies
3.5 Global Telmisartan Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Telmisartan Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Telmisartan Product Type
3.8 Tier 1, Tier 2 and Tier 3 Telmisartan Players in Global Market
3.8.1 List of Global Tier 1 Telmisartan Companies
3.8.2 List of Global Tier 2 and Tier 3 Telmisartan Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Telmisartan Market Size Markets, 2021 & 2027
4.1.2 Injection
4.1.3 Freeze-Dried Powder
4.2 By Type - Global Telmisartan Revenue & Forecasts
4.2.1 By Type - Global Telmisartan Revenue, 2016-2021
4.2.2 By Type - Global Telmisartan Revenue, 2022-2027
4.2.3 By Type - Global Telmisartan Revenue Market Share, 2016-2027
4.3 By Type - Global Telmisartan Sales & Forecasts
4.3.1 By Type - Global Telmisartan Sales, 2016-2021
4.3.2 By Type - Global Telmisartan Sales, 2022-2027
4.3.3 By Type - Global Telmisartan Sales Market Share, 2016-2027
4.4 By Type - Global Telmisartan Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Telmisartan Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Telmisartan Revenue & Forecasts
5.2.1 By Application - Global Telmisartan Revenue, 2016-2021
5.2.2 By Application - Global Telmisartan Revenue, 2022-2027
5.2.3 By Application - Global Telmisartan Revenue Market Share, 2016-2027
5.3 By Application - Global Telmisartan Sales & Forecasts
5.3.1 By Application - Global Telmisartan Sales, 2016-2021
5.3.2 By Application - Global Telmisartan Sales, 2022-2027
5.3.3 By Application - Global Telmisartan Sales Market Share, 2016-2027
5.4 By Application - Global Telmisartan Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Telmisartan Market Size, 2021 & 2027
6.2 By Region - Global Telmisartan Revenue & Forecasts
6.2.1 By Region - Global Telmisartan Revenue, 2016-2021
6.2.2 By Region - Global Telmisartan Revenue, 2022-2027
6.2.3 By Region - Global Telmisartan Revenue Market Share, 2016-2027
6.3 By Region - Global Telmisartan Sales & Forecasts
6.3.1 By Region - Global Telmisartan Sales, 2016-2021
6.3.2 By Region - Global Telmisartan Sales, 2022-2027
6.3.3 By Region - Global Telmisartan Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Telmisartan Revenue, 2016-2027
6.4.2 By Country - North America Telmisartan Sales, 2016-2027
6.4.3 US Telmisartan Market Size, 2016-2027
6.4.4 Canada Telmisartan Market Size, 2016-2027
6.4.5 Mexico Telmisartan Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Telmisartan Revenue, 2016-2027
6.5.2 By Country - Europe Telmisartan Sales, 2016-2027
6.5.3 Germany Telmisartan Market Size, 2016-2027
6.5.4 France Telmisartan Market Size, 2016-2027
6.5.5 U.K. Telmisartan Market Size, 2016-2027
6.5.6 Italy Telmisartan Market Size, 2016-2027
6.5.7 Russia Telmisartan Market Size, 2016-2027
6.5.8 Nordic Countries Telmisartan Market Size, 2016-2027
6.5.9 Benelux Telmisartan Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Telmisartan Revenue, 2016-2027
6.6.2 By Region - Asia Telmisartan Sales, 2016-2027
6.6.3 China Telmisartan Market Size, 2016-2027
6.6.4 Japan Telmisartan Market Size, 2016-2027
6.6.5 South Korea Telmisartan Market Size, 2016-2027
6.6.6 Southeast Asia Telmisartan Market Size, 2016-2027
6.6.7 India Telmisartan Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Telmisartan Revenue, 2016-2027
6.7.2 By Country - South America Telmisartan Sales, 2016-2027
6.7.3 Brazil Telmisartan Market Size, 2016-2027
6.7.4 Argentina Telmisartan Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Telmisartan Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Telmisartan Sales, 2016-2027
6.8.3 Turkey Telmisartan Market Size, 2016-2027
6.8.4 Israel Telmisartan Market Size, 2016-2027
6.8.5 Saudi Arabia Telmisartan Market Size, 2016-2027
6.8.6 UAE Telmisartan Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Telmisartan Major Product Offerings
7.1.4 Pfizer Telmisartan Sales and Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Teva
7.2.1 Teva Corporate Summary
7.2.2 Teva Business Overview
7.2.3 Teva Telmisartan Major Product Offerings
7.2.4 Teva Telmisartan Sales and Revenue in Global (2016-2021)
7.2.5 Teva Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Telmisartan Major Product Offerings
7.3.4 Boehringer Ingelheim Telmisartan Sales and Revenue in Global (2016-2021)
7.3.5 Boehringer Ingelheim Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Telmisartan Major Product Offerings
7.4.4 Novartis Telmisartan Sales and Revenue in Global (2016-2021)
7.4.5 Novartis Key News
7.5 Mylan
7.5.1 Mylan Corporate Summary
7.5.2 Mylan Business Overview
7.5.3 Mylan Telmisartan Major Product Offerings
7.5.4 Mylan Telmisartan Sales and Revenue in Global (2016-2021)
7.5.5 Mylan Key News
7.6 Reddy's Laboratories (UK)
7.6.1 Reddy's Laboratories (UK) Corporate Summary
7.6.2 Reddy's Laboratories (UK) Business Overview
7.6.3 Reddy's Laboratories (UK) Telmisartan Major Product Offerings
7.6.4 Reddy's Laboratories (UK) Telmisartan Sales and Revenue in Global (2016-2021)
7.6.5 Reddy's Laboratories (UK) Key News
7.7 Hema Pharmaceuticals Pvt
7.7.1 Hema Pharmaceuticals Pvt Corporate Summary
7.7.2 Hema Pharmaceuticals Pvt Business Overview
7.7.3 Hema Pharmaceuticals Pvt Telmisartan Major Product Offerings
7.4.4 Hema Pharmaceuticals Pvt Telmisartan Sales and Revenue in Global (2016-2021)
7.7.5 Hema Pharmaceuticals Pvt Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Telmisartan Major Product Offerings
7.8.4 Bayer Telmisartan Sales and Revenue in Global (2016-2021)
7.8.5 Bayer Key News
7.9 GSK
7.9.1 GSK Corporate Summary
7.9.2 GSK Business Overview
7.9.3 GSK Telmisartan Major Product Offerings
7.9.4 GSK Telmisartan Sales and Revenue in Global (2016-2021)
7.9.5 GSK Key News
7.10 Astellas Pharma Inc
7.10.1 Astellas Pharma Inc Corporate Summary
7.10.2 Astellas Pharma Inc Business Overview
7.10.3 Astellas Pharma Inc Telmisartan Major Product Offerings
7.10.4 Astellas Pharma Inc Telmisartan Sales and Revenue in Global (2016-2021)
7.10.5 Astellas Pharma Inc Key News
7.11 Nippon Boehringer Ingelheim
7.11.1 Nippon Boehringer Ingelheim Corporate Summary
7.11.2 Nippon Boehringer Ingelheim Telmisartan Business Overview
7.11.3 Nippon Boehringer Ingelheim Telmisartan Major Product Offerings
7.11.4 Nippon Boehringer Ingelheim Telmisartan Sales and Revenue in Global (2016-2021)
7.11.5 Nippon Boehringer Ingelheim Key News
7.12 Abbott
7.12.1 Abbott Corporate Summary
7.12.2 Abbott Telmisartan Business Overview
7.12.3 Abbott Telmisartan Major Product Offerings
7.12.4 Abbott Telmisartan Sales and Revenue in Global (2016-2021)
7.12.5 Abbott Key News
7.13 Takeda
7.13.1 Takeda Corporate Summary
7.13.2 Takeda Telmisartan Business Overview
7.13.3 Takeda Telmisartan Major Product Offerings
7.13.4 Takeda Telmisartan Sales and Revenue in Global (2016-2021)
7.13.5 Takeda Key News
7.14 Beijing Wansheng Pharmaceutical
7.14.1 Beijing Wansheng Pharmaceutical Corporate Summary
7.14.2 Beijing Wansheng Pharmaceutical Business Overview
7.14.3 Beijing Wansheng Pharmaceutical Telmisartan Major Product Offerings
7.14.4 Beijing Wansheng Pharmaceutical Telmisartan Sales and Revenue in Global (2016-2021)
7.14.5 Beijing Wansheng Pharmaceutical Key News
8 Global Telmisartan Production Capacity, Analysis
8.1 Global Telmisartan Production Capacity, 2016-2027
8.2 Telmisartan Production Capacity of Key Manufacturers in Global Market
8.3 Global Telmisartan Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Telmisartan Supply Chain Analysis
10.1 Telmisartan Industry Value Chain
10.2 Telmisartan Upstream Market
10.3 Telmisartan Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Telmisartan Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Telmisartan in Global Market
Table 2. Top Telmisartan Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Telmisartan Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Telmisartan Revenue Share by Companies, 2016-2021
Table 5. Global Telmisartan Sales by Companies, (MT), 2016-2021
Table 6. Global Telmisartan Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Telmisartan Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Telmisartan Product Type
Table 9. List of Global Tier 1 Telmisartan Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Telmisartan Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Telmisartan Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Telmisartan Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Telmisartan Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Telmisartan Sales (MT), 2016-2021
Table 15. By Type - Global Telmisartan Sales (MT), 2022-2027
Table 16. By Application - Global Telmisartan Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Telmisartan Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Telmisartan Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Telmisartan Sales (MT), 2016-2021
Table 20. By Application - Global Telmisartan Sales (MT), 2022-2027
Table 21. By Region - Global Telmisartan Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Telmisartan Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Telmisartan Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Telmisartan Sales (MT), 2016-2021
Table 25. By Region - Global Telmisartan Sales (MT), 2022-2027
Table 26. By Country - North America Telmisartan Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Telmisartan Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Telmisartan Sales, (MT), 2016-2021
Table 29. By Country - North America Telmisartan Sales, (MT), 2022-2027
Table 30. By Country - Europe Telmisartan Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Telmisartan Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Telmisartan Sales, (MT), 2016-2021
Table 33. By Country - Europe Telmisartan Sales, (MT), 2022-2027
Table 34. By Region - Asia Telmisartan Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Telmisartan Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Telmisartan Sales, (MT), 2016-2021
Table 37. By Region - Asia Telmisartan Sales, (MT), 2022-2027
Table 38. By Country - South America Telmisartan Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Telmisartan Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Telmisartan Sales, (MT), 2016-2021
Table 41. By Country - South America Telmisartan Sales, (MT), 2022-2027
Table 42. By Country - Middle East & Africa Telmisartan Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Telmisartan Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Telmisartan Sales, (MT), 2016-2021
Table 45. By Country - Middle East & Africa Telmisartan Sales, (MT), 2022-2027
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Telmisartan Product Offerings
Table 48. Pfizer Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 49. Teva Corporate Summary
Table 50. Teva Telmisartan Product Offerings
Table 51. Teva Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Telmisartan Product Offerings
Table 54. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 55. Novartis Corporate Summary
Table 56. Novartis Telmisartan Product Offerings
Table 57. Novartis Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 58. Mylan Corporate Summary
Table 59. Mylan Telmisartan Product Offerings
Table 60. Mylan Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 61. Reddy's Laboratories (UK) Corporate Summary
Table 62. Reddy's Laboratories (UK) Telmisartan Product Offerings
Table 63. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 64. Hema Pharmaceuticals Pvt Corporate Summary
Table 65. Hema Pharmaceuticals Pvt Telmisartan Product Offerings
Table 66. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 67. Bayer Corporate Summary
Table 68. Bayer Telmisartan Product Offerings
Table 69. Bayer Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 70. GSK Corporate Summary
Table 71. GSK Telmisartan Product Offerings
Table 72. GSK Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 73. Astellas Pharma Inc Corporate Summary
Table 74. Astellas Pharma Inc Telmisartan Product Offerings
Table 75. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 76. Nippon Boehringer Ingelheim Corporate Summary
Table 77. Nippon Boehringer Ingelheim Telmisartan Product Offerings
Table 78. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 79. Abbott Corporate Summary
Table 80. Abbott Telmisartan Product Offerings
Table 81. Abbott Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 82. Takeda Corporate Summary
Table 83. Takeda Telmisartan Product Offerings
Table 84. Takeda Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 85. Beijing Wansheng Pharmaceutical Corporate Summary
Table 86. Beijing Wansheng Pharmaceutical Telmisartan Product Offerings
Table 87. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 88. Telmisartan Production Capacity (MT) of Key Manufacturers in Global Market, 2019-2021 (MT)
Table 89. Global Telmisartan Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Global Telmisartan Production by Region, 2016-2021 (MT)
Table 91. Global Telmisartan Production by Region, 2022-2027 (MT)
Table 92. Telmisartan Market Opportunities & Trends in Global Market
Table 93. Telmisartan Market Drivers in Global Market
Table 94. Telmisartan Market Restraints in Global Market
Table 95. Telmisartan Raw Materials
Table 96. Telmisartan Raw Materials Suppliers in Global Market
Table 97. Typical Telmisartan Downstream
Table 98. Telmisartan Downstream Clients in Global Market
Table 99. Telmisartan Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Telmisartan Segment by Type
Figure 2. Telmisartan Segment by Application
Figure 3. Global Telmisartan Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Telmisartan Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Telmisartan Revenue, 2016-2027 (US$, Mn)
Figure 7. Telmisartan Sales in Global Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Telmisartan Revenue in 2020
Figure 9. By Type - Global Telmisartan Sales Market Share, 2016-2027
Figure 10. By Type - Global Telmisartan Revenue Market Share, 2016-2027
Figure 11. By Type - Global Telmisartan Price (USD/Kg), 2016-2027
Figure 12. By Application - Global Telmisartan Sales Market Share, 2016-2027
Figure 13. By Application - Global Telmisartan Revenue Market Share, 2016-2027
Figure 14. By Application - Global Telmisartan Price (USD/Kg), 2016-2027
Figure 15. By Region - Global Telmisartan Sales Market Share, 2016-2027
Figure 16. By Region - Global Telmisartan Revenue Market Share, 2016-2027
Figure 17. By Country - North America Telmisartan Revenue Market Share, 2016-2027
Figure 18. By Country - North America Telmisartan Sales Market Share, 2016-2027
Figure 19. US Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Telmisartan Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Telmisartan Sales Market Share, 2016-2027
Figure 24. Germany Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 25. France Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Telmisartan Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Telmisartan Sales Market Share, 2016-2027
Figure 33. China Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 37. India Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Telmisartan Revenue Market Share, 2016-2027
Figure 39. By Country - South America Telmisartan Sales Market Share, 2016-2027
Figure 40. Brazil Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Telmisartan Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Telmisartan Sales Market Share, 2016-2027
Figure 44. Turkey Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Telmisartan Revenue, (US$, Mn), 2016-2027
Figure 48. Global Telmisartan Production Capacity (MT), 2016-2027
Figure 49. The Percentage of Production Telmisartan by Region, 2020 VS 2027
Figure 50. Telmisartan Industry Value Chain
Figure 51. Marketing Channels
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs